FDA Approves Updated Covid-19 Vaccines, But Restrictions Limit Access for Younger Groups

Strategic Insights -

The US Food and Drug Administration has approved updated Covid-19 vaccines for adults 65 and older, as well as younger individuals who are at higher risk from Covid-19. However, the approvals come with significant restrictions that limit access to these vaccines for younger, healthier individuals. The updated vaccines target coronavirus strains circulating more recently, but emergency use authorizations for Covid-19 vaccines have been rescinded, which means Pfizer's Covid-19 vaccine is no longer authorized for children younger than 5.

Key Takeaways:

  • The FDA has approved updated Covid-19 vaccines for adults 65 and older, as well as younger individuals who are at higher risk from Covid-19.
  • The approvals include Moderna's Spikevax vaccine for children as young as 6 months, but only if they have an underlying condition that puts them at higher risk.
  • Emergency use authorizations for Covid-19 vaccines have been rescinded, which means Pfizer's Covid-19 vaccine is no longer authorized for children younger than 5.
  • The FDA decision restricts access to Covid-19 vaccines for younger, healthier individuals, who may need to seek "off-label" vaccination with their healthcare provider's consent.
  • Many health conditions increase the risk of severe illness and hospitalization from Covid-19, including lung, heart, and kidney conditions, obesity, cancer, HIV, and pregnancy.
  • The new FDA decision "completely contradicts the evidence base" and "severely undermines trust in science-driven policy," according to Dr. Tina Tan, president of the Infectious Diseases Society of America.

Statistics:

  • There were 48 Covid-19 hospitalizations for every 100,000 children under 5 during the last respiratory virus season, nearly seven times the rate for older children and more than twice the rate for adults under 50, according to CDC data.
  • There were about 1.7 Covid hospitalizations for every 100,000 people during the first week of August, with the highest rates among seniors and children under 5, according to CDC data.
  • Surveillance data from WastewaterSCAN suggests that virus levels are about half of what they were during the peak of last summer's surge, but they match the peak from the summer of 2023.
  • The American Academy of Pediatrics recommends Covid-19 shots for infants and young children, breaking from the CDC's decision.

Sources:

  • CNN - HHS Secretary Robert F. Kennedy Jr. post on X
  • CNN - interview with Dr. Tina Tan, president of the Infectious Diseases Society of America
  • CNN - statement from Dr. Susan Kressly, president of the American Academy of Pediatrics
  • CDC - immunization schedule update
  • CDC - surveillance data from WastewaterSCAN
  • American Academy of Pediatrics - recommendation for Covid-19 shots for infants and young children